Fios Genomics bioinformatics team and services move to Excelra
Fios Genomics, based in
"This is about continuity and making a larger impact for our clients," said
"Fios is known for rigorous, study-level analysis delivered quickly and explained clearly, exactly what researchers need when a dataset lands," said
"Fios has built a team of bioinformaticians that clients trust with their hardest questions, and we are delighted to welcome them to Excelra," said Anandbir Singh Brar, CEO of Excelra. "Omics data keeps growing, but the questions don't change: which target? which indication? which patients? Pairing Fios' scientific depth with our own bioinformatics, data, and AI-native engineering means we can answer those questions even faster and with more confidence."
Fios clients can reach the team at [email protected]
About Excelra
Excelra engineers trust into AI-driven R&D, combining AI-ready data and platforms, including GOSTAR, connected lab informatics, and multi-omics expertise to turn R&D complexity into decisions you can defend. Science led. Data driven. Outcomes focused.
About Fios Genomics
Founded in 2008 as a University of Edinburgh spin-out, Fios Genomics has delivered bioinformatics analysis and biological interpretation across genomics, transcriptomics and multi-omics studies to pharma, biotech, and life science researchers worldwide.
Contact
Prashant Sharma
[email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/fios-genomics-bioinformatics-team-and-services-move-to-excelra-302918010.html
SOURCE Excelra
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bloomberg Tax & Accounting to Honor 2026 International Tax Author Award Winners
- New Rule of Law Study Reveals America's Diminishing Belief in Democracy
- Altea Enters US Healthcare Insurance Market, Appoints Justin Rodrick as Vice President
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share